Wealth Enhancement Advisory Services’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44M Sell
157,861
-1,863
-1% -$20.8K ﹤0.01% 1909
2026
Q2
$1.57M Buy
159,724
+43,682
+38% +$412K ﹤0.01% 1741
2026
Q1
$849K Buy
116,042
+735
+0.6% +$6.31K ﹤0.01% 1920
2025
Q4
$1.1M Buy
115,307
+24,252
+27% +$254K ﹤0.01% 1894
2025
Q3
$859K Buy
91,055
+34,143
+60% +$243K ﹤0.01% 1962
2025
Q2
$334K Buy
56,912
+35,779
+169% +$219K ﹤0.01% 2560
2025
Q1
$139K Buy
+21,133
New +$165K ﹤0.01% 2699

Other funds holding KURA

Wealth Enhancement Advisory Services's KURA Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Kura Oncology (KURA) stake by 1.2% in Q3 2026, selling an estimated $20.8K and leaving 157,861 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

Wealth Enhancement Advisory Services first reported a position in KURA in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.57M in Q2 2026. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Wealth Enhancement Advisory Services held 157,861 shares of Kura Oncology worth $1.44M as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 1,863 Kura Oncology shares in Q3 2026, an estimated $20.8K.
  • Kura Oncology made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #1909 holding.
  • Wealth Enhancement Advisory Services first reported a position in Kura Oncology in Q1 2025 and has held it in 7 quarters since.
  • Wealth Enhancement Advisory Services's Kura Oncology position peaked at $1.57M in Q2 2026.
  • 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.